Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and β-adrenoceptor blockers

Bulletin of Experimental Biology and Medicine

Volumn 141, Issue 1, 2006, Pages 40-43

  Fedorov, V N ^a   Sal'nikov, E V ^a   Sidorov, A V ^a   Bogatushin, A V ^a   Fateev, M M ^a  

^a YAROSLAVL STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

adrenoceptor blockers; Angiotensin converting enzyme inhibitors; Experimental chronic heart failure; Lifetime; Survival

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CELIPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIROTON; ENALAPRIL MALEATE; LISINOPRIL; METOCARD; METOPROLOL; NEBIVOLOL; PINDOLOL; PROPRANOLOL; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LIFESPAN; MORTALITY; NONHUMAN; RAT; SURVIVAL TIME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIAC OUTPUT, LOW; DISEASE MODELS, ANIMAL; RATS; RATS, INBRED STRAINS;

ANIMALIA;

EID: 33745089698     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0088-1     Document Type: Article

References (9)

1. G. P. Arutyunov, Zh. Serdech. Nedostatoch., 5, No. 2, 64-65 (2004).
2. G. P. Arutyunov and A. K. Rylova, Ibid., 2, No. 2, 92-94 (2001).
3. S. Glants, Medical and Biological Statistics [in Russian], Moscow (1999).
4. T. A. Gus'kova, Khim.-Farm. Zh., No. 7, 10-15 (1990).
5. A. G. Obrezan and I. V. Vologdina, Chronic Heart Failure [in Russian], St. Petersburg (2002).
6. 1 Receptor Antagonists in Clinical Practice [in Russian], Moscow (2002).
7. V. N. Fedorov, A. L. Khokhlov, and O. V. Smirnova, Ros. Kardiol. Zh., 33, No. 1, 56-58 (2002).
8. M. Bristow, Circulation, No. 101, 558-569 (2000).
9. P. A. Poole-Wilson, R. Swedberg, J. G. F. Cleland, et al., Lancet, No. 362, 7-14 (2003).